Cargando…

Serum creatine phosphokinase in the detection of carriers of Duchenne's muscular dystrophy in Northern Ireland.

Detalles Bibliográficos
Autores principales:	McCormick, D., Allen, I. V.
Formato:	Texto
Lenguaje:	English
Publicado:	Ulster Medical Society 1976
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2385554/ https://www.ncbi.nlm.nih.gov/pubmed/936362

Ejemplares similares

PLASMA CREATINE PHOSPHOKINASE IN SCHIZOPHRENIA
por: Kondaiah, P., et al.
Publicado: (1981)

Correlation of Serum Creatine Kinase Level With Pulmonary Function in Duchenne Muscular Dystrophy
por: Kim, Eun Young, et al.
Publicado: (2017)

Relationship of Levetiracetam and Serum Creatine Phosphokinase in Children with Epilepsy
por: Panda, Prateek Kumar, et al.
Publicado: (2021)

Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy
por: Gruber, Dorota, et al.
Publicado: (2022)

Serum creatine phosphokinase as predictor of intermediate syndrome in organophosphorus poisoning
por: Kumar, G. Chetan, et al.
Publicado: (2015)

Carrier detection in Duchenne muscular dystrophy using molecular methods
por: Sakthivel Murugan, S.M., et al.
Publicado: (2013)

Non-Invasive Biomarkers for Duchenne Muscular Dystrophy and Carrier Detection
por: Anaya-Segura, Mónica Alejandra, et al.
Publicado: (2015)

Creatine phosphokinase elevation exacerbated by levetiracetam therapy
por: Isaacson, Julia E., et al.
Publicado: (2014)

ELEVATED CREATINE PHOSPHOKINASE IN PATIENTS WITH COVID-19
por: BHALLA, SUSHEN, et al.
Publicado: (2022)

Serum Creatine Phosphokinase: A Probable Marker of Severity in Organophosphorus Poisoning
por: Bhattacharyya, Kuntal, et al.
Publicado: (2011)

Effect of Levetiracetam Usage on Serum Creatine Phosphokinase Concentration in Patients with Epilepsy
por: Incecik, Faruk, et al.
Publicado: (2020)

Is Serum Creatine Phosphokinase Level Useful to Predict the Severity of Organophosphate Poisoning?
por: Biswas, Subrata, et al.
Publicado: (2022)

Utility of MLPA in mutation analysis and carrier detection for Duchenne muscular dystrophy
por: Verma, Prashant K., et al.
Publicado: (2012)

Serum MyomiRs as Biomarkers for Female Carriers of Duchenne/Becker Muscular Dystrophy
por: Zhang, Jiapeng, et al.
Publicado: (2020)

Assessment of The Diagnostic Capability of Serum Creatine Phosphokinase and Its Isoenzyme in Ectopic Pregnancy
por: Ghahiri, Attaollah, et al.
Publicado: (2012)

Association of creatine phosphokinase with the cytoskeleton of cultured mammalian cells
Publicado: (1980)

Population-Wide Duchenne Muscular Dystrophy Carrier Detection by CK and Molecular Testing
por: Han, Shuai, et al.
Publicado: (2020)

Corrigendum: Serum MyomiRs as Biomarkers for Female Carriers of Duchenne/Becker Muscular Dystrophy
por: Zhang, Jiapeng, et al.
Publicado: (2020)

Carrier Woman of Duchenne Muscular Dystrophy Mimicking Inflammatory Myositis
por: Yoon, Jiyeol, et al.
Publicado: (2011)

Patterns of late gadolinium enhancement in Duchenne muscular dystrophy carriers
por: Giglio, Vincenzo, et al.
Publicado: (2014)

Serum Levels of MicroRNA-206 and Novel Mini-STR Assays for Carrier Detection in Duchenne Muscular Dystrophy
por: Anaya-Segura, Mónica Alejandra, et al.
Publicado: (2016)

Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)

Three Cases of Manifesting Female Carriers in Patients with Duchenne Muscular Dystrophy
por: Song, Tae-Jin, et al.
Publicado: (2011)

miRNAs as serum biomarkers for Duchenne muscular dystrophy
por: Cacchiarelli, Davide, et al.
Publicado: (2011)

Clinical utility of serum biomarkers in Duchenne muscular dystrophy
por: Hathout, Yetrib, et al.
Publicado: (2016)

Predictive Value of Serum Myoglobin and Creatine Phosphokinase for Development of Acute Kidney Injury in Traumatic Rhabdomyolysis
por: Raju, Nithin Abraham, et al.
Publicado: (2017)

The association between serum uric acid and creatine phosphokinase in the general population: NHANES 2015–2018
por: Chen, Xinxin, et al.
Publicado: (2023)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Experiences of Women Who Have Had Carrier Testing for Duchenne Muscular Dystrophy and Becker Muscular Dystrophy During Adolescence
por: Fraser, Harry G., et al.
Publicado: (2018)

Differences in carrier frequency between mothers of Duchenne and Becker muscular dystrophy patients
por: Lee, Tomoko, et al.
Publicado: (2014)

A manifesting female carrier of Duchenne muscular dystrophy: importance of genetics for the dystrophinopathies
por: Quak, Zhi Xuan, et al.
Publicado: (2023)

Uncommon serum creatine phosphokinase and lactic dehydrogenase increase during diosmin therapy: two case reports
por: Milano, Giulia, et al.
Publicado: (2014)

Evaluation of serum creatine phosphokinase in diagnosis of tubal ectopic pregnancy compared with intrauterine pregnancy and threatened abortion
por: Asgharnia, Maryam, et al.
Publicado: (2012)

Extraordinary Creatine Phosphokinase Levels in Coxsackie B Necrotizing Myopathy Complicated by Rhabdomyolysis
por: Alex, Jacob, et al.
Publicado: (2022)

Monkeypox virus infection and creatine phosphokinase increase: A case from Italy
por: Pipitò, Luca, et al.
Publicado: (2022)

Physiologic Response to Exercise or Rhabdomyolysis? Creatine Phosphokinase Elevation in 16 Asymptomatic Firefighters
por: Arbab, Rajia, et al.
Publicado: (2022)

Hypokalemia complicating Duchenne muscular dystrophy.
por: McDonald, B., et al.
Publicado: (1987)

The role of fibrosis in Duchenne muscular dystrophy
por: KLINGLER, WERNER, et al.
Publicado: (2012)

Delay in Diagnosis of Duchenne Muscular Dystrophy
por: Rao, Vamshi K., et al.
Publicado: (2015)

Circulating Biomarkers for Duchenne Muscular Dystrophy
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tp8h6j8e5eskddutbiq677kppl